A blood gas test measures the amount of oxygen and carbon dioxide in the blood. It is also used to determine the pH and acidic content of the blood. The test is commonly known as a blood gas analysis or arterial blood gas (ABG) test. Imbalances in the oxygen, carbon dioxide, and pH levels of your blood indicate the presence of certain medical conditions. These products are used in emergency departments for the diagnosis of various diseases including kidney failure, heart failure, uncontrolled diabetes, hemorrhage, chemical poisoning, a drug overdose, shock, asthma, and chronic obstructive pulmonary disorder (COPD). Research Beam Model: Research Beam Product ID: 1547712 5370 USD New
Blood Gas and Electrolyte Analyzers Market Allied Market Research
 

Blood Gas and Electrolyte Analyzers Market by Type [Analyzers/Instruments by Product Type (Blood Gas Analyzers, Electrolyte Analyzers, and Combined Analyzers), and Modality (Portable, Benchtop, and Laboratory) and Consumables], Product/Brand (i-STAT, GEM Premier, ABL Flex, RAPID Series, Cobas, and Others), and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Blood Gas and Electrolyte Analyzers Market by Type [Analyzers/Instruments by Product Type (Blood Gas Analyzers, Electrolyte Analyzers, and Combined An

Category : Diagnostic and Biotech
Published On : April  2017
Pages : 150

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

A blood gas test measures the amount of oxygen and carbon dioxide in the blood. It is also used to determine the pH and acidic content of the blood. The test is commonly known as a blood gas analysis or arterial blood gas (ABG) test. Imbalances in the oxygen, carbon dioxide, and pH levels of your blood indicate the presence of certain medical conditions. These products are used in emergency departments for the diagnosis of various diseases including kidney failure, heart failure, uncontrolled diabetes, hemorrhage, chemical poisoning, a drug overdose, shock, asthma, and chronic obstructive pulmonary disorder (COPD).

The global blood gas and electrolyte analyzers market was valued at $1,427 million in 2016, and is estimated to garner $2,104 million by 2023, registering a CAGR of 5.7% from 2017 to 2023. The major factors that enhance the market growth are growth in number of patients being treated in ICUs, NICUs, and emergency departments; rise in patients suffering from chronic diseases; and increase in number of product approvals. However, complexity involved in interpretation of data acts as a restraining factor for the market growth.
 
The global blood gas and electrolyte analyzers market is segmented by type, product/brand, end user, and geography. Based on type, it is classified into analyzers/instruments and consumables. Analyzers/instruments is further sub segmented into product type and modality. Based on product type, it is categorized into blood gas analyzers, electrolyte analyzers, and combined analyzers. Based on modality, it is divided into laboratory, benchtop, and portable.

By product/brand, it is classified into i-Stat, ePOC, GEM Premier, ABL Flex, Cobas, RAPID Series, and other blood gas analyzer. Based on end user, it is categorized into hospitals, clinics, ambulatory surgical centers(ASC), and others. Geographically, it is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA. The North America market accounted for significant share in the global market in 2016, owing to growth in number of patients admitted in the ICUs, NICUs, and emergency department.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global blood gas and electrolyte analyzers market and the current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides quantitative analysis of the industry from 2016 to 2023 to enable stakeholders to capitalize on the prevailing opportunities.
  • Extensive analysis of the market based on the type, product/brand, and end user elucidate the prevailing opportunities in these segments.
  • Comprehensive analysis of geographical regions is provided to determine the latent regional opportunities.
  • The key players operating and their strategies in the market are profiled to determine the competitive outlook of the market.

Blood Gas and Electrolyte Analyzers Market Key Segments:

BY TYPE

  • Analyzers/Instruments
    • Product Type
      • Blood Gas Analyzers
      • Electrolyte Analyzers
      • Combined Analyzers
    • Modality
      • Portable
      • Benchtop
      • Laboratory
  • Consumables

BY PRODUCT/BRAND

  • i-Stat (Abbott Laboratories)
  • ePOC (Alere, Inc.)
  • GEM Premier (Instrumentation Laboratory)
  • ABL Flex (Radiometer)
  • Cobas (Roche Diagnostics)
  • RAPID Series (Siemens Healthineers)
  • Others

BY END USER

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers(ASC)
  • Others

BY GEOGRAPHY

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Radiometer Medical Aps (A Subsidiary of Danaher Corporation)
  • Instrumentation Laboratory (A Werfen Company)
  • Siemens AG
  • Roche Diagnostics Limited
  • Abbott Laboratories, Inc.
  • Nova Biomedical
  • OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.)
  • ERBA Diagnostics Mannheim GmbH
  • Medica Corporation
  • Alere, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN

  • (These players are not profiled in the report, but can be included on request)
  • Samsung Medison
  • Edan Instruments
  • Convergent Technologies
  • Dalko Diagnostics
  • Afford Medical Technologies
  • Accurex Biomedical Pvt. Ltd.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTERS FIVE FORCES ANALYSIS

3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry

3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Growing number of patients being treated in ICUs, NICUs, and emergency departments
3.5.1.2. Increase in geriatric population and surge in incidence and prevalence of chronic diseases
3.5.1.3. Technological advancement in blood gas and electrolyte analyzers

3.5.2. Restraints

3.5.2.1. Complexity involved in interpretation of data

3.5.3. Opportunities

3.5.3.1. Developing economies offer lucrative growth opportunities

CHAPTER 4 BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY TYPE

4.1. OVERVIEW
4.2. ANALYZERS/INSTRUMENTS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Market by product type

4.2.4.1. Blood gas analyzers

4.2.4.1.1 Market size and forecast

4.2.4.2. Electrolyte analyzers

4.2.4.2.1. Market size and forecast

4.2.4.3. Combined analyzers

4.2.4.3.1. Market size and forecast

4.2.5. Market by modality

4.2.5.1. Laboratory

4.2.5.1.1. Market size and forecast

4.2.5.2. Benchtop

4.2.5.2.1. Market size and forecast

4.2.5.3. Portable

4.2.5.3.1. Market size and forecast

4.3. CONSUMABLES

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY PRODUCT/BRAND

5.1. OVERVIEW
5.2. I-STAT

5.2.1. Market size and forecast

5.3. GEM PREMIER

5.3.1. Market size and forecast

5.4. ABL FLEX

5.4.1. Market size and forecast

5.5. COBAS

5.5.1. Market size and forecast

5.6. RAPID SERIES

5.6.1. Market size and forecast

5.7. OTHER

5.7.1. Market size and forecast

CHAPTER 6 BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY END USER

6.1. OVERVIEW
6.2. HOSPITAL

6.2.1. Market size and forecast

6.3. CLINICS

6.3.1. Market size and forecast

6.4. AMBULATORY SURGICAL CENTERS

6.4.1. Market size and forecast

6.5. OTHERS

6.5.1. Market size and forecast

CHAPTER 7 BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.: market size and forecast
7.2.5. Canada: market size and forecast
7.2.6. Mexico: market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany: market size and forecast
7.3.5. France market size and forecast
7.3.6. UK: market size and forecast
7.3.7. Italy: market size and forecast
7.3.8. Spain: market size and forecast
7.3.9. Rest of Europe: market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan: market size and forecast
7.4.5. China market size and forecast
7.4.6. India: market size and forecast
7.4.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Latin America: market size and forecast
7.5.5. Middle East market size and forecast
7.5.6. Africa: market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES, INC.

8.1.1. Overview
8.1.2. Operating business segments
8.1.3. Business performance

8.2. ALERE, INC.

8.2.1. Overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves & developments

8.3. ERBA DIAGNOSTICS MANNHEIM GMBH

8.3.1. Overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves & developments

8.4. INSTRUMENTATION LABORATORY

8.4.1. Overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves & developments

8.5. MEDICA CORPORATION

8.5.1. Overview
8.5.2. Operating business segments
8.5.3. Business performance
8.5.4. Key strategic moves & developments

8.6. NOVA BIOMEDICAL

8.6.1. Overview
8.6.2. Operating business segments
8.6.3. Business performance

8.7. OPTI MEDICAL SYSTEMS, INC

8.7.1. Overview
8.7.2. Operating business segments
8.7.3. Business performance

8.8. RADIOMETER MEDICAL APS(A SUBSIDIARY OF DANAHER CORPORATION)

8.8.1. Overview
8.8.2. Operating business segments
8.8.3. Business performance

8.9. ROCHE DIAGNOSTICS LIMITED

8.9.1. Overview
8.9.2. Operating business segments
8.9.3. Business performance
8.9.4. Key strategic moves & developments

8.10. SIEMENS AG

8.10.1. Overview
8.10.2. Operating business segments
8.10.3. Business performance

LIST OF TABLES

TABLE 1. GLOBAL INCIDENCE RATES OF DISEASES
TABLE 2. GLOBAL BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY TYPE, 2016-2023, ($ MILLION)
TABLE 3. GLOBAL BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET FOR ANALYZERS/INSTRUMENTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. GLOBAL BLOOD GAS AND ELECTROLYTE ANAYLZERS/INSTRUMENTS MARKET, BY PRODUCT TYPE, 2016-2023, ($ MILLION)
TABLE 5. GLOBAL BLOOD GAS ANAYLZERS/INSTRUMENTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. GLOBAL ELECTROLYTE ANAYLZERS/INSTRUMENTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 7. GLOBAL COMBINED ANAYLZERS/INSTRUMENTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. GLOBAL BLOOD GAS AND ELECTROLYTE ANAYLZERS/INSTRUMENTS MARKET, BY MODALITY, 2016-2023, ($ MILLION)
TABLE 9. GLOBAL LABORATORY BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL BENCHTOP BLOOD GAS AND ELECTROLYTE ANALYZER MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11. GLOBAL PORTABLE BLOOD GAS AND ELECTROLYTE ANALYZER MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. GLOBAL CONSUMABLE BLOOD GAS AND ELECTROLYTE ANALYZER MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13. GLOBAL BLOOD GAS AND ELECTROLYTE ANALYZER MARKET, BY PRODUCT/BRAND, 2016-2023 ($ MILLION)
TABLE 14. GLOBAL I-STAT BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 15. GLOBAL GEM PREMIER BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 16. GLOBAL ABL FLEX BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. GLOBAL COBAS BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18. GLOBAL RAPID SERIES BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19. GLOBAL OTHER BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 20. GLOBAL BLOOD GAS AND ELECTROLYTE ANALYZER MARKET, BY END USER, 2016-2023 ($ MILLION)
TABLE 21. GLOBAL BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET FOR HOSPITALS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22. GLOBAL BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET FOR CLINICS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23. GLOBAL BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24. GLOBAL BLOOD GAS AND ELECTROLYTE ANALYZER MARKET FOR OTHER END USER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 25. GLOBAL BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 26. NORTH AMERICA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. NORTH AMERICA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 28. NORTH AMERICA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY PRODUCT/BRAND, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 30. EUROPE: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 31. EUROPE: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 32. EUROPE: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY PRODUCT/BRAND, 2016-2023 ($MILLION)
TABLE 33. EUROPE: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 34. ASIA-PACIFIC: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2016-2023($MILLION)
TABLE 35. ASIA-PACIFIC: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 36. ASIA-PACIFIC: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY PRODUCT/BRAND, 2016-2023 ($MILLION)
TABLE 37. ASIA-PACIFIC: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 38. LAMEA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2016-2023($MILLION)
TABLE 39. LAMEA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 40. LAMEA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY PRODUCT/BRAND, 2016-2023 ($MILLION)
TABLE 41. LAMEA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 42 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 43 ABBOTT LABORATORIES, INC.: BUSINESS SEGMENTS
TABLE 44 ALERE, INC.: COMPANY SNAPSHOT
TABLE 45 ALERE, INC.: BUSINESS SEGMENTS
TABLE 46 ERBA DIAGNOSTICS MANNHEIM GMBH: COMPANY SNAPSHOT
TABLE 47 ERBA DIAGNOSTICS MANNHEIM GMBH: BUSINESS SEGMENTS
TABLE 48 INSTRUMENTATION LABORATORY: COMPANY SNAPSHOT
TABLE 49 INSTRUMENTATION LABORATORY: BUSINESS SEGMENTS
TABLE 50 MEDICA CORPORATION: COMPANY SNAPSHOT
TABLE 51 MEDICA CORPORATION: BUSINESS SEGMENTS
TABLE 52 NOVA BIOMEDICAL: COMPANY SNAPSHOT
TABLE 53 NOVA BIOMEDICAL: BUSINESS SEGMENTS
TABLE 54 OPTI MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
TABLE 55 OPTI MEDICAL SYSTEMS, INC.: BUSINESS SEGMENTS
TABLE 56 RADIOMETER MEDICAL APS: COMPANY SNAPSHOT
TABLE 57 RADIOMETER MEDICAL APS: BUSINESS SEGMENTS
TABLE 58 ROCHE DIAGNOSTICS LIMITED: COMPANY SNAPSHOT
TABLE 59 ROCHE DIAGNOSTICS LIMITED: BUSINESS SEGMENTS
TABLE 60 SIEMENS AG: COMPANY SNAPSHOT
TABLE 61 SIEMENS AG: BUSINESS SEGMENTS

LIST OF FIGURES

FIGURE 1. BLOOD GAS AND ELECTROLYTE ANALYZERS: MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS IN BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET
FIGURE 3. MARKET SHARE ANALYSIS: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016
FIGURE 9. INCIDENCE RATE OF CHRONIC DISEASES, 1995-2030
FIGURE 10. U.S.: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 11. CANADA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 12. MEXICO: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 13. GERMANY: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 14. FRANCE: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 15. UK: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 16. ITALY: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 17. SPAIN: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 18. REST OF EUROPE: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 19. JAPAN: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 20. CHINA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 21. INDIA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 22. REST OF ASIA-PACIFIC: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 23. LATIN AMERICA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 24. MIDDLE EAST: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 25. AFRICA: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 26. ABBOTT LABORATORIES, INC. - TOTAL REVENUE, 2014-2016 ($MILLION)
FIGURE 27. ABBOTT LABORATORIES, INC. - REVENUE, BY PRODUCT CATEGORY, 2016 (%)
FIGURE 28. ABBOTT LABORATORIES, INC. - REVENUE, BY GEOGRAPHY, 2016 (%)
FIGURE 29. INSTRUMENTATION LABORATORY - TOTAL REVENUE, 2014-2016 ($MILLION)
FIGURE 30. INSTRUMENTATION LABORATORY - REVENUE, BY GEOGRAPHY, 2016 (%)
FIGURE 31. OPTI MEDICAL SYSTEMS, INC. - TOTAL REVENUE, 2013-2015 ($MILLION)
FIGURE 32. OPTI MEDICAL SYSTEMS, INC. - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 33. OPTI MEDICAL SYSTEMS, INC. - REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 34. RADIOMETER MEDICAL APS - TOTAL REVENUE, 2013-2015 ($MILLION)
FIGURE 35. RADIOMETER MEDICAL APS - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 36. RADIOMETER MEDICAL APS - REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 37. ROCHE DIAGNOSTICS LIMITED -TOTAL REVENUE, 2013-2015 ($MILLION)
FIGURE 38. ROCHE DIAGNOSTICS LIMITED- REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 39. ROCHE DIAGNOSTICS LIMITED -REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 40. SIEMENS AG - TOTAL REVENUE, 2013-2015 ($MILLION)
FIGURE 41. SIEMENS AG - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 42. SIEMENS AG: REVENUE, BY GEOGRAPHY, 2015 (%)

Enquiry Before Buy